COVID-19 infodemics: the role of mainstream and social media

Affiliations

¹ North-Western Tuscany Blood Bank, Pisa, Italy.
² Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
³ Department of Medicine and Surgery, Laboratory of Microbiology, ASST Sette Laghi, University of Insubria, Varese, Italy.
⁴ Third Department of Pediatrics, School of Medicine, Aristotle University, Hippokration General Hospital, Thessaloniki, Greece.
⁵ Department of Molecular Medicine, University Hospital "Policlinico Umberto I", Sapienza University, Rome, Italy. Electronic address: guido.antonelli@uniroma1.it.

Daniele Focosi et al. Clin Microbiol Infect. 2021 Nov.

. 2021 Nov;27(11):1568-1569.

doi: 10.1016/j.cmi.2021.08.003. Epub 2021 Aug 8.

¹ North-Western Tuscany Blood Bank, Pisa, Italy.
² Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
³ Department of Medicine and Surgery, Laboratory of Microbiology, ASST Sette Laghi, University of Insubria, Varese, Italy.
⁴ Third Department of Pediatrics, School of Medicine, Aristotle University, Hippokration General Hospital, Thessaloniki, Greece.
⁵ Department of Molecular Medicine, University Hospital "Policlinico Umberto I", Sapienza University, Rome, Italy. Electronic address: guido.antonelli@uniroma1.it.

No abstract available

References

1. F Robson K.S., Khan T.K., Le C., Paris S., Demirbag P., Barfuss P., et al. Coronavirus RNA proofreading: molecular basis and therapeutic targeting. Mol Cell. 2020;79:710–727. - PMC - PubMed
1. Focosi D., Maggi F. Neutralising antibody escape of SARS-CoV-2 spike protein: risk assessment for antibody-based Covid-19 therapeutics and vaccines. Rev Med Virol. 2021 In press. - PMC - PubMed
1. Antonelli G., Anastasi E., Ciprani F., Cabral R.J.R., Ialongo C., Capobianchi M.R., et al. Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab. Lancet Microbe. 2021;2:e178. - PMC - PubMed
1. Focosi D., Franchini M. 2021. COVID-19 convalescent plasma therapy: hit fast, hit hard! Vox Sang. In press. - PMC - PubMed
1. Casadevall A., Dragotakes Q., Johnson P.W., Senefeld J.W., Klassen S.S., Wright S.R., et al. Convalescent plasma use in the United States was inversely correlated with COVID-19 mortality: did convalescent plasma hesitancy cost lives? eLife. 2021;4 - PMC - PubMed